OTC:FOSUY

Fosun Receives RMB12 Billion Syndicated Loan to Consolidate Capital for Business Development

Retrieved on: 
星期二, 一月 17, 2023
The Bund Finance Center, Bank of China, News, Fosun Pharma, PE, COFCO, Attention, Bank, Agricultural Bank, Club Med, China International Capital Corporation, CICC, Industrial and Commercial Bank of China, COVID-19, Statistics, HKEX, Commercial bank, Health, Pfizer–BioNTech COVID-19 vaccine, Communication, Security, China Minsheng Bank, Exim Bank, Iron, Happiness, NAV, Central Economic Work Conference, Conference, Environmental Effects of Illicit Drug Production, Policy, Tsingtao Brewery, Omicron, China Construction Bank, Research, New Year, Bank of Communications, Shanghai Pudong Development Bank, Nanjing Iron and Steel Company, Research report, Agricultural Bank of China, Optimism, Security (finance), Risk management, Fosun International, Azvudine

According to the Company's official release, Guo Guangchang, Chairman of Fosun International said that this signing has further deepened the cooperation between Fosun and banks, broadened financing channels, and consolidated liquidity support for business development.

Key Points: 
  • According to the Company's official release, Guo Guangchang, Chairman of Fosun International said that this signing has further deepened the cooperation between Fosun and banks, broadened financing channels, and consolidated liquidity support for business development.
  • Before the RMB12 billion syndicated loan was officially completed, on 13 January, Fosun High Technology successfully completed bookbuilding for the RMB1 billion super & short-term commercial paper "23 Fosun High Technology SCP001" with a term of 180 days and a coupon rate of 6.99% per annum.
  • The super & short-term commercial paper is Fosun High Technology's first issuance since its return to the public market at the end of April 2022.
  • In addition to this syndicated loan and the super & short-term commercial paper, Fosun's capital has been further consolidated.

Fosun International Receives Four Awards from Corporate Governance Asia

Retrieved on: 
星期三, 一月 11, 2023
Government, Education, HKEX, ESG, RNA transfection, Vaccination, COVID-19, Virus, Best, Fosun Pharma, Growth, Patient, JD, Qiyu Zhou, Malaria, Asian Excellence Awards, Social responsibility, ABC Family Worldwide, Omicron, Health, Culture, BioNTech, Taiwan Excellence Awards, The Bund Finance Center, Human, COVID, Management, Pharmaceutical industry, Fosun International, Azvudine

HONG KONG, Jan. 11, 2023 /PRNewswire/ -- On 11 January 2023, the Corporate Governance Asia magazine presented the 12th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited ("Fosun International" or "Fosun" or the "Group") (HKEX: 00656) were both honoured Asia's Best CEO. In addition, Fosun International was awarded Asia's Best CSR and Best Corporate Communications awards.

Key Points: 
  • Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited ("Fosun International" or "Fosun" or the "Group") (HKEX: 00656) were both honoured Asia's Best CEO.
  • Corporate Governance Asia is one of the most authoritative corporate governance journals in the Asian-Pacific region.
  • Chen Qiyu, Executive Director and Co-CEO of Fosun International, said, "We are very honoured to receive several awards from Corporate Governance Asia, including Asia's Best CEO and Asia's Best CSR.
  • According to Corporate Governance Asia, in response to the pandemic, Fosun took the initiative to undertake corporate social responsibility.

Fosun International Garners Multiple ESG Awards in Domestic and International Markets

Retrieved on: 
星期五, 十二月 30, 2022
Benchmark, Sustainable Development Goals, Vaccination, Patient, CSR (company), United Nations, Morgan Stanley, Hang Seng China 50 Index, Environment, United Nations Global Compact, Fosun Pharma, Hang Seng Index, Goldman Sachs, RNA transfection, Omicron, COVID-19, ABC Family Worldwide, FTSE Russell, Conference, Face, Hang Seng Composite Index Series, MSCI, UN, Government, First Nations in Ontario, Consumer, BioNTech, Pfizer–BioNTech COVID-19 vaccine, ESG, Citigroup, Film, Vaccine, Pharmaceutical industry, Renewable energy, Lithium, Azvudine, Fosun International

HONG KONG, Dec. 29, 2022 /PRNewswire/ -- Recently, Fosun International received numerous accolades in domestic and international markets, including multiple ESG awards from international financial media International Business Magazine, Finance Derivative and Hong Kong stock connect information platform Zhitong Caijing.

Key Points: 
  • HONG KONG, Dec. 29, 2022 /PRNewswire/ -- Recently, Fosun International received numerous accolades in domestic and international markets, including multiple ESG awards from international financial media International Business Magazine, Finance Derivative and Hong Kong stock connect information platform Zhitong Caijing.
  • A number of investment banks, including Morgan Stanley, Citi, and Goldman Sachs, have published reports and assigned Fosun International an "Overweight" or "Buy" rating.
  • Since 2019, Fosun International has established the ESG Board Committee and the ESG Working Group to comprehensively improve ESG management and ensure the implementation of each ESG indicator.
  • Fosun International has also established an ESG Management Committee as well as an ESG Executive Committee to promote the effective implementation of ESG strategies and initiatives.

Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom

Retrieved on: 
星期五, 十二月 23, 2022
Benchmark, Vaccination, Corporate social responsibility, Teaching hospital, Ernst & Young Entrepreneur of the Year Award, Hang Seng China 50 Index, Gunnerus Sustainability Award, Fosun Pharma, Infrastructure Development Company, CSR, RNA transfection, Hang Seng Index, Omicron, Social responsibility, Insurance, COVID-19, ABC Family Worldwide, Islam, FTSE Russell, Face, Hang Seng Composite Index Series, Global Banking & Finance Review, MSCI, United Kingdom, Government, BioNTech, Sustainable development, Pfizer–BioNTech COVID-19 vaccine, ESG, Vaccine, Lithium, Fosun International

HONG KONG, Dec. 22, 2022 /PRNewswire/ -- On 23 December 2022, Fosun International was notified by Global Banking and Finance Review, a famous financial magazine in the United Kingdom, that Fosun International was granted three awards, namely "Brand of the Year Awards - Holding Group Brand of the Year Awards Asia 2022", "ESG & Sustainability Awards - Best Sustainable Development Company Asia 2022" and "Corporate Social Responsibility (CSR) Awards - Best CSR Company Asia 2022", respectively.

Key Points: 
  • HONG KONG, Dec. 22, 2022 /PRNewswire/ -- On 23 December 2022, Fosun International was notified by Global Banking and Finance Review, a famous financial magazine in the United Kingdom, that Fosun International was granted three awards, namely "Brand of the Year Awards - Holding Group Brand of the Year Awards Asia 2022", "ESG & Sustainability Awards - Best Sustainable Development Company Asia 2022" and "Corporate Social Responsibility (CSR) Awards - Best CSR Company Asia 2022", respectively.
  • Fosun has been awarded by Global Banking and Finance Review in recognition of Fosun's active promotion in the sustainable development and ESG.
  • Global Banking and Finance Review Magazine is a leading magazine in the United Kingdom.
  • The Global Banking and Finance Review Awards were established in 2011 to accomplish companies with outstanding performances within the global finance industry.

Guo Guangchang looks back on Fosun's 30 years and reveals the future development direction of Fosun

Retrieved on: 
星期一, 十二月 19, 2022
Acquisition, Speech, Fosun Pharma, BioNTech, Vaccination, Health, Chinese New Year, Happiness, Omicron, Club Med, Pressure, LANV, Face, RNA transfection, Patient, Epidemic, Growth, Lanvin, COVID-19, Wolford, Nightclub, Retail, Pharmaceutical industry, Vaccine, Azvudine, Fosun International

Market analysts believe that Fosun is actively making strategic focus in the face of the constant changes in the macro environment.

Key Points: 
  • Market analysts believe that Fosun is actively making strategic focus in the face of the constant changes in the macro environment.
  • On 15 December, Fosun held the Fosun's 30th Anniversary ONE FOSUN Family Members' Carnival.
  • In Guo Guangchang's speech on 15 December, he shared the moment of the successful acquisition of Club Med in 2015.
  • Guo Guangchang said, "BioNTech, a Germany biotechnology company, chose to cooperate with Fosun to develop the COVID-19 mRNA vaccine because they recognize Fosun Pharma's research and development capabilities and globalization strategy.

Club Med Kiroro Peak Opens in Hokkaido, Japan, Lanvin Group Lists on the New York Stock Exchange, Guo Guangchang looks back on Fosun's 30 years and reveals the future development direction of Fosun

Retrieved on: 
星期五, 十二月 16, 2022
Vaccination, Speech, Omicron, Club Med, Patient, Fosun Pharma, LANV, Epidemic, BioNTech, Happiness, Lanvin, COVID-19, Face, RNA transfection, Growth, Chinese New Year, Wolford, Health, Pressure, Acquisition, Nightclub, Retail, Pharmaceutical industry, Vaccine, Fosun International, Azvudine

On the morning of 15 December, Club Med under Fosun Tourism Group opened Club Med Kiroro Peak in Hokkaido, Japan, which is the fifth resort newly opened by Club Med this year.

Key Points: 
  • On the morning of 15 December, Club Med under Fosun Tourism Group opened Club Med Kiroro Peak in Hokkaido, Japan, which is the fifth resort newly opened by Club Med this year.
  • In Guo Guangchang's speech on 15 December, he shared the moment of the successful acquisition of Club Med in 2015.
  • "The acquisition of Club Med is an important milestone in Fosun's globalization history, and Club Med is our first brand with global significance."
  • He said, "I believe that the significance of Club Med and Fosun Tourism Group is far beyond resorts, it represents a new way of life for families."

Fosun International Receives "ESG Leading Enterprise Award" and "ESG Leading Social Initiative Award" from Bloomberg Businessweek/Chinese Edition

Retrieved on: 
星期三, 十二月 14, 2022
Benchmark, Vaccination, Artesunate, New World Development, Hang Seng Composite Index Series, MSCI, Ecosystem, Bank, Bloomberg Businessweek, FTSE Russell, Omicron, InvestHK, Partnership, Hang Seng China 50 Index, Patient, ESG, Contribution, Fosun Pharma, Hang Seng Index, Sun Hung Kai Properties, The London Institute of Banking & Finance, Malaria, BioNTech, Happiness, COVID-19, Face, RNA transfection, Hang Seng Bank, ABC Family Worldwide, Social responsibility, Government, Henderson Land Development, McIntire Investment Institute, Lithium, Pharmaceutical industry, Fosun International

Fosun International has garnered the "ESG Leading Enterprise Award" in the Category I - Market capitalization over HK$20 billion and the "ESG Leading Social Initiative Award".

Key Points: 
  • Fosun International has garnered the "ESG Leading Enterprise Award" in the Category I - Market capitalization over HK$20 billion and the "ESG Leading Social Initiative Award".
  • This year, Fosun International was accredited with the "ESG Leading Enterprise Award" in the Category I - Market capitalization over HK$20 billion by Bloomberg Businessweek/Chinese Edition, representing the market's recognition of Fosun International in environmental, social, corporate governance (ESG), corporate sustainability, and information disclosure, etc.
  • As a globalized company rooted in China, Fosun takes initiatives to create business value and gives high priorities to corporate social responsibility.
  • Fosun International has also established an ESG Management Committee as well as an ESG Executive Committee to promote the effective implementation of ESG strategies and initiatives.